• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浆膜下血管密度可预测T2期胆囊癌的肿瘤学特征。

Subserosal vascular density predicts oncological features of T2 gallbladder cancer.

作者信息

Akabane Miho, Shindoh Junichi, Kohno Kei, Okubo Satoshi, Matsumura Masaru, Takazawa Yutaka, Hashimoto Masaji

机构信息

Department of Gastroenterological Surgery, Hepatobiliary-Pancreatic Surgery Division, Toranomon Hospital, 2-2-2 Toranomon, Minatoku, Tokyo, 105-8470, Japan.

Okinaka Memorial Institute for Medical Disease, Tokyo, Japan.

出版信息

Langenbecks Arch Surg. 2023 Feb 1;408(1):73. doi: 10.1007/s00423-023-02823-6.

DOI:10.1007/s00423-023-02823-6
PMID:36725735
Abstract

PURPOSE

Tumor sidedness (hepatic side vs. peritoneal side) reportedly predicts microvascular invasion and survival outcomes of T2 gallbladder cancer, although the actual histopathological mechanism is not fully understood.

METHODS

The clinical relevance of tumor sidedness was revisited in 84 patients with gallbladder cancer using histopathological analysis of the vascular density of the gallbladder wall.

RESULTS

Hepatic-side tumor location was associated with overall survival (OS) (hazard ratio [HR], 13.62; 95% confidence interval [CI], 2.09-88.93) and recurrence-free survival (RFS) (HR, 8.70; 95% CI, 1.36-55.69) in T2 tumors. The Adjusted Kaplan-Meier curve indicated a clear survival difference between T2a (peritoneal side) and T2b (hepatic side) tumors (P = 0.006). A review of 56 pathological specimens with gallbladder cancer and 20 control specimens demonstrated that subserosal vascular density was significantly higher on the hepatic side of the gallbladder, regardless of the presence of cancer (P < 0.001). Multivariate analysis also confirmed that higher subserosal vascular density was significantly associated with poor OS (HR, 1.73; 95% CI, 1.10-2.73 per 10 microscopic fields) and poor RFS (HR, 1.62; 95% CI, 1.06-2.49) in T2  gallbladder cancer.

CONCLUSION

Higher subserosal vascular density may account for the higher incidence of cancer spread and the poor prognosis of T2b gallbladder cancer.

摘要

目的

据报道,肿瘤位置(肝侧与腹膜侧)可预测T2期胆囊癌的微血管侵犯及生存结局,但其实际组织病理学机制尚未完全明确。

方法

通过对84例胆囊癌患者胆囊壁血管密度进行组织病理学分析,重新探讨肿瘤位置的临床相关性。

结果

肝侧肿瘤位置与T2期肿瘤的总生存期(OS)(风险比[HR],13.62;95%置信区间[CI],2.09 - 88.93)及无复发生存期(RFS)(HR,8.70;95% CI,1.36 - 55.69)相关。校正后的Kaplan-Meier曲线显示,T2a(腹膜侧)和T2b(肝侧)肿瘤之间存在明显的生存差异(P = 0.006)。对56例胆囊癌病理标本和20例对照标本的回顾显示,无论有无癌症,胆囊肝侧的浆膜下血管密度均显著更高(P < 0.001)。多因素分析还证实,在T2期胆囊癌中,较高的浆膜下血管密度与较差的OS(HR,1.73;95% CI,每10个显微镜视野1.10 - 2.73)及较差的RFS(HR,1.62;95% CI,1.06 - 2.49)显著相关。

结论

较高的浆膜下血管密度可能是T2b期胆囊癌癌症扩散发生率较高及预后较差的原因。

相似文献

1
Subserosal vascular density predicts oncological features of T2 gallbladder cancer.浆膜下血管密度可预测T2期胆囊癌的肿瘤学特征。
Langenbecks Arch Surg. 2023 Feb 1;408(1):73. doi: 10.1007/s00423-023-02823-6.
2
Tumor location is a strong predictor of tumor progression and survival in T2 gallbladder cancer: an international multicenter study.肿瘤位置是T2期胆囊癌肿瘤进展和生存的有力预测指标:一项国际多中心研究。
Ann Surg. 2015 Apr;261(4):733-9. doi: 10.1097/SLA.0000000000000728.
3
Comparing survival rate and appropriate surgery methods according to tumor location in T2 gallbladder cancer.比较 T2 期胆囊癌肿瘤位置与生存率及合适手术方式的关系。
Surg Oncol. 2022 Mar;40:101693. doi: 10.1016/j.suronc.2021.101693. Epub 2021 Dec 8.
4
Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? Results of a retrospective multicenter study.对于T2期胆囊癌患者,肝侧肿瘤是否比腹膜侧肿瘤需要更广泛的切除?一项回顾性多中心研究的结果
Surgery. 2017 Sep;162(3):515-524. doi: 10.1016/j.surg.2017.05.004. Epub 2017 Jun 16.
5
Validation of the oncologic effect of hepatic resection for T2 gallbladder cancer: a retrospective study.验证肝切除术治疗 T2 期胆囊癌的肿瘤学疗效:一项回顾性研究。
World J Surg Oncol. 2019 Jan 7;17(1):8. doi: 10.1186/s12957-018-1556-6.
6
Role of tumour location and surgical extent on prognosis in T2 gallbladder cancer: an international multicentre study.肿瘤位置和手术范围对 T2 期胆囊癌预后的作用:一项国际多中心研究。
Br J Surg. 2020 Sep;107(10):1334-1343. doi: 10.1002/bjs.11618. Epub 2020 May 26.
7
Clinicopathological Differences in T2 Gallbladder Cancer According to Tumor Location.根据肿瘤位置的不同,T2 期胆囊癌的临床病理差异。
Cancer Control. 2020 Jan-Dec;27(1):1073274820915514. doi: 10.1177/1073274820915514.
8
Systematic review and meta-analysis of survival outcomes in T2a and T2b gallbladder cancers.T2a 和 T2b 期胆囊癌生存结局的系统评价和荟萃分析。
HPB (Oxford). 2022 Jun;24(6):789-796. doi: 10.1016/j.hpb.2021.12.019. Epub 2021 Dec 30.
9
Surgical treatment of patients with T2 gallbladder carcinoma invading the subserosal layer.侵犯浆膜下层的T2期胆囊癌患者的外科治疗
J Am Coll Surg. 2001 May;192(5):600-7. doi: 10.1016/s1072-7515(01)00814-6.
10
Incidental versus non-incidental gallbladder cancer: index cholecystectomy before oncologic re-resection negatively impacts survival in T2b tumors.偶然与非偶然胆囊癌:在 T2b 肿瘤中,术前意外胆囊癌行指数性胆囊切除术对肿瘤再次切除后的生存有负面影响。
HPB (Oxford). 2019 Aug;21(8):1046-1056. doi: 10.1016/j.hpb.2018.12.006. Epub 2019 Jan 31.

本文引用的文献

1
Applicability of sentinel lymph node oriented treatment strategy for gallbladder cancer.前哨淋巴结导向治疗策略在胆囊癌中的应用。
PLoS One. 2021 Feb 12;16(2):e0247079. doi: 10.1371/journal.pone.0247079. eCollection 2021.
2
Prognostic impact of tumor location in resected gallbladder cancer: A national cohort analysis.切除胆囊癌肿瘤位置对预后的影响:全国队列分析。
J Surg Oncol. 2020 Nov;122(6):1084-1093. doi: 10.1002/jso.26107. Epub 2020 Jul 11.
3
Role of tumour location and surgical extent on prognosis in T2 gallbladder cancer: an international multicentre study.
肿瘤位置和手术范围对 T2 期胆囊癌预后的作用:一项国际多中心研究。
Br J Surg. 2020 Sep;107(10):1334-1343. doi: 10.1002/bjs.11618. Epub 2020 May 26.
4
Clinicopathological Differences in T2 Gallbladder Cancer According to Tumor Location.根据肿瘤位置的不同,T2 期胆囊癌的临床病理差异。
Cancer Control. 2020 Jan-Dec;27(1):1073274820915514. doi: 10.1177/1073274820915514.
5
Validation of the 8th Edition of the American Joint Committee on Cancer Staging System for Gallbladder Cancer and Implications for the Follow-up of Patients without Node Dissection.验证第 8 版美国癌症联合委员会胆囊癌分期系统及其对未行淋巴结清扫患者随访的影响。
Cancer Res Treat. 2020 Apr;52(2):455-468. doi: 10.4143/crt.2019.271. Epub 2019 Oct 17.
6
Lymphatic spread of T2 gallbladder carcinoma: Regional lymphadenectomy is required independent of tumor location.T2 期胆囊癌的淋巴转移:区域性淋巴结清扫术是必需的,与肿瘤位置无关。
Eur J Surg Oncol. 2019 Aug;45(8):1446-1452. doi: 10.1016/j.ejso.2019.03.038. Epub 2019 Mar 30.
7
Validation of the oncologic effect of hepatic resection for T2 gallbladder cancer: a retrospective study.验证肝切除术治疗 T2 期胆囊癌的肿瘤学疗效:一项回顾性研究。
World J Surg Oncol. 2019 Jan 7;17(1):8. doi: 10.1186/s12957-018-1556-6.
8
Prognostic validation of the updated 8th edition Tumor-Node-Metastasis classification by the Union for International Cancer Control: Survival analyses of 307 patients with surgically treated gallbladder carcinoma.国际癌症控制联盟对第8版肿瘤-淋巴结-转移分期系统更新版的预后验证:307例接受手术治疗的胆囊癌患者的生存分析
Oncol Lett. 2018 Oct;16(4):4427-4433. doi: 10.3892/ol.2018.9189. Epub 2018 Jul 23.
9
The optimal surgical resection approach for T2 gallbladder carcinoma: evaluating the role of surgical extent according to the tumor location.T2期胆囊癌的最佳手术切除方法:根据肿瘤位置评估手术范围的作用。
Ann Surg Treat Res. 2018 Mar;94(3):135-141. doi: 10.4174/astr.2018.94.3.135. Epub 2018 Feb 28.
10
Do hepatic-sided tumors require more extensive resection than peritoneal-sided tumors in patients with T2 gallbladder cancer? Results of a retrospective multicenter study.对于T2期胆囊癌患者,肝侧肿瘤是否比腹膜侧肿瘤需要更广泛的切除?一项回顾性多中心研究的结果
Surgery. 2017 Sep;162(3):515-524. doi: 10.1016/j.surg.2017.05.004. Epub 2017 Jun 16.